Scleromyxedema is a scleroderma-like disorder and not a coexistance of scleroderma with papular mucinosis

European Journal of Dermatology

Volumn 9, Issue 7, 1999, Pages 551-554

  Jablonska, Stefania ^a   Blaszczyk, Maria ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Papular mucinosis; Paraproteinemia; Scleroderma like changes; Scleromyxedema

Indexed keywords

ADULT; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SIMULATION; FEMALE; HUMAN; MALE; MUCINOSIS; MYOSITIS; PARAPROTEINEMIA; PROGNOSIS; SCLERODERMA; SCLEROMYXEDEMA; SCLEROSIS; SYSTEMIC SCLEROSIS;

ADULT; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MUCINOSES; MYXEDEMA; SCLERODERMA, SYSTEMIC; SKIN; SKIN DISEASES;

EID: 0032695966     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Jablonska S, Blaszczyk M. Differential diagnosis of scleroderma-like disorders. In: Clements PJ, Furst DE, eds. Systemic sclerosis. Baltimore: Williams and Wilkins, 1995: 99-120.
2. Jablonska S, Blaszczyk M. Scleroderma-like disorders. Sem Cutaneous Med Surg 1998; 17: 65-76.
3. Sawada Y, Seishima M, Funabashi M, Noda T, Maeda M, Kitajima Y. Papular mucinosis associated with scleroderma. Eur J Dermatol 1998; 8: 497-500.
4. Gottron HA. Skleromyxedem (eine eigenartige Erscheinungsform von Myxothesaurodermie). Arch Dermatol 1954; 199: 71-91.
5. Harris AO, Altman AR, Tschen JA, Wolf JE. Scleromyxedema: report of two cases and review of the literature. Int J Dermatol 1989; 28: 661-7.
6. Verity MA, Toop J, McAdam LP, Pearson CM. Scleromyxedema myopathy: histochemical and electron microscopic observations. Am J Clin Pathol 1978; 69: 446-51.
7. Fudman EJ, Golbus J, Ike RW. Scleromyxedema with systemic involvement mimics rheumatic diseases. Arthritis Rheum 1986; 29: 913-7.
8. Gabriel SE, Perry HO, Oleson GB, Bowles CA. Scleromyxedema: a scleroderma-like disorder with systemic manifestations. Medicine 1988; 67: 58-65.
9. Goodby A, Bergstresser PR, Chaker B, Pandya AG. Fatal scleromyxedema: report of a case and review of the literature. J Am Acad Dermatol 1998; 38: 289-94.
10. Kantor GR, Bergfeld WF, Katzin WE, Reynolds OD, Biscardi AP, Lobur DM, et al. Scleromyxedema associated with scleroderma renal disease and acute psychosis. J Am Acad Dermatol 1986; 14: 879-88.
11. McAdam LP, Pearson CM, Pitts WH, Sadoff L, Verity MA. Popular mucinosis with myopathy, arthritis, and eosinophilia: a histopathologic study. Arthritis Rheum 1977; 20: 989-95.
12. Howsden SM, Herndon JH Jr, Freeman RG. Lichen myxedematosus: a dermal infiltrative disorder responsive to cyclophosphamide therapy. Arch Dermatol 1975; 111: 1325-30.
13. Harris RB, Perry HO, Kyle RA, Winkelmann RK. Treatment of scleromyxedema with melphalan. Arch Dermatol 1979; 115: 295-9.
14. Harper RA, Rispler J. Lichen myxedematosus serum stimulates human skin fibroblast proliferation. Science 1978; 188: 545-7.
15. Ferrarini M, Helfrich DJ, Walker ER, Medsger TA, Whiteside TL. Scleromyxedema serum increases proliferation but not the glycosaminoglycan synthesis of dermal fibroblasts. J Rheumatol 1989; 16: 837-41.
16. Jablonska S. Scleroderma and Pseudoscleroderma. Warsaw : Polish Med Publ, English edition (Dowden Hutchinson Ross Inc. Stroudsburg Pal, 1975.
17. Hardie RA, Hunter JAA, Urbaniak S, Habeshaw JA. Spontaneous resolution of lichen myxoedematosus. Br J Dermatol 1979; 100: 727-30.
18. Boffa MJ, Ead RD. Spontaneous improvement of scleromyxedema. Clin Exp Dermatol 1995; 20: 157-60.